文献速递间质性肺疾病

基于HRCT定量气道分析预测特发性肺纤维化患者预后

Prognostication in patients with idiopathic pulmonary fibrosis using quantitative airway analysis from HRCT: a retrospective study.
PubMed 文献 · Eur Respir J · 2025-10-16

本研究利用AI模型SABRE对1284例弥漫性纤维化性肺疾病患者的HRCT进行气道定量分析,发现SABRE变量可独立预测死亡和疾病进展,且联合DLCO可显著提高预后效能,1年AUC为0.852,C-index为0.752。

要点

  • SABRE气道定量变量是IPF患者死亡和进展的独立预测因子。
  • SABRE联合DLCO可提升预后预测效能,1年AUC达0.852。
  • SABRE预测信号超越传统指标、疾病严重度评分及已有AI方法。

核心结论

  • SABRE气道变量可提供超越传统测量、疾病严重度评分和已有AI方法的预后信息。

研究设计与样本

  • 回顾性研究,纳入1744例接受HRCT扫描的匿名患者,其中1284例有弥漫性纤维化性肺疾病证据用于临床分析。

主要发现

  • Cox回归显示SABRE变量是死亡和进展的独立预测因子,校正疾病严重度、传统指标及已有深度学习算法后仍显著。
  • SABRE联合DLCO的1年AUC为0.852,C-index为0.752。

临床怎么用

  • SABRE气道定量分析可用于IPF患者基线风险分层,辅助抗纤维化治疗优先级决策。

局限性

  • 回顾性研究设计。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Predicting shorter life expectancy is crucial for prioritising antifibrotic therapy in fibrotic lung diseases (FLDs), where progression varies widely, from stability to rapid deterioration. This heterogeneity complicates treatment decisions, emphasising the need for reliable baseline measures. This study focuses on leveraging an artificial intelligence (AI) model to address heterogeneity in disease outcomes, focusing on mortality as the ultimate measure of disease trajectory. METHODS: This retrospective study included 1744 anonymised patients who underwent high-resolution computed tomography (HRCT) scanning. The AI model, SABRE (Smart Airway Biomarker Recognition Engine), was developed using data from patients with various lung diseases (n=460, including lung cancer, pneumonia, emphysema and fibrosis). Then, 1284 HRCT scans with evidence of diffuse FLD from the Australian Idiopathic Pulmonary Fibrosis Registry and Open Source Imaging Consortium were used for clinical analyses. Airway branches were categorised and quantified by anatomical structures and volumes, followed by multivariable analysis to explore the associations between these categories and patients' progression and mortality, adjusting for disease severity or traditional measurements. RESULTS: Cox regression identified SABRE-based variables as independent predictors of mortality and progression, even adjusting for disease severity (fibrosis extent, traction bronchiectasis extent and interstitial lung disease extent), traditional measures (forced vital capacity percentage predicted, diffusing capacity of the lung for carbon monoxide (D LCO) percentage predicted and composite physiological index), and previously reported deep learning algorithms for fibrosis quantification and morphological analysis. Combining SABRE with D LCO significantly improved prognosis utility, yielding an area under the curve of 0.852 at the first year and a C-index of 0.752. CONCLUSIONS: SABRE-based variables capture prognostic signals beyond that provided by traditional measurements, disease severity scores and established AI-based methods, reflecting the progressiveness and pathogenesis of the disease.

来源:Eur Respir J,查看原文。版权归原作者所有。

引用

  1. Nan Y, Felder FN, Humphries S, et al. Prognostication in patients with idiopathic pulmonary fibrosis using quantitative airway analysis from HRCT: a retrospective study. Eur Respir J. 2025. PMID: 40744692. doi:10.1183/13993003.00981-2025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。